QQQ   272.11 (-0.14%)
AAPL   456.91 (-0.68%)
MSFT   208.82 (+0.06%)
FB   261.31 (+0.00%)
GOOGL   1,509.05 (-0.50%)
AMZN   3,142.86 (-0.57%)
NVDA   460.04 (+0.51%)
CGC   17.20 (-0.69%)
BABA   253.00 (-0.28%)
TSLA   1,642.77 (+1.34%)
GE   6.67 (+1.06%)
MU   45.84 (-0.65%)
AMD   81.25 (-0.72%)
T   30.02 (+0.37%)
F   7.05 (+0.28%)
ACB   10.72 (+5.30%)
GILD   68.61 (+0.63%)
NFLX   481.56 (+0.05%)
DIS   130.23 (-0.56%)
BAC   26.39 (+0.15%)
BA   177.71 (+1.71%)
QQQ   272.11 (-0.14%)
AAPL   456.91 (-0.68%)
MSFT   208.82 (+0.06%)
FB   261.31 (+0.00%)
GOOGL   1,509.05 (-0.50%)
AMZN   3,142.86 (-0.57%)
NVDA   460.04 (+0.51%)
CGC   17.20 (-0.69%)
BABA   253.00 (-0.28%)
TSLA   1,642.77 (+1.34%)
GE   6.67 (+1.06%)
MU   45.84 (-0.65%)
AMD   81.25 (-0.72%)
T   30.02 (+0.37%)
F   7.05 (+0.28%)
ACB   10.72 (+5.30%)
GILD   68.61 (+0.63%)
NFLX   481.56 (+0.05%)
DIS   130.23 (-0.56%)
BAC   26.39 (+0.15%)
BA   177.71 (+1.71%)
QQQ   272.11 (-0.14%)
AAPL   456.91 (-0.68%)
MSFT   208.82 (+0.06%)
FB   261.31 (+0.00%)
GOOGL   1,509.05 (-0.50%)
AMZN   3,142.86 (-0.57%)
NVDA   460.04 (+0.51%)
CGC   17.20 (-0.69%)
BABA   253.00 (-0.28%)
TSLA   1,642.77 (+1.34%)
GE   6.67 (+1.06%)
MU   45.84 (-0.65%)
AMD   81.25 (-0.72%)
T   30.02 (+0.37%)
F   7.05 (+0.28%)
ACB   10.72 (+5.30%)
GILD   68.61 (+0.63%)
NFLX   481.56 (+0.05%)
DIS   130.23 (-0.56%)
BAC   26.39 (+0.15%)
BA   177.71 (+1.71%)
QQQ   272.11 (-0.14%)
AAPL   456.91 (-0.68%)
MSFT   208.82 (+0.06%)
FB   261.31 (+0.00%)
GOOGL   1,509.05 (-0.50%)
AMZN   3,142.86 (-0.57%)
NVDA   460.04 (+0.51%)
CGC   17.20 (-0.69%)
BABA   253.00 (-0.28%)
TSLA   1,642.77 (+1.34%)
GE   6.67 (+1.06%)
MU   45.84 (-0.65%)
AMD   81.25 (-0.72%)
T   30.02 (+0.37%)
F   7.05 (+0.28%)
ACB   10.72 (+5.30%)
GILD   68.61 (+0.63%)
NFLX   481.56 (+0.05%)
DIS   130.23 (-0.56%)
BAC   26.39 (+0.15%)
BA   177.71 (+1.71%)
Log in

NASDAQ:OPNTOpiant Pharmaceuticals News Headlines

$9.05
-0.02 (-0.22 %)
(As of 08/14/2020 03:19 PM ET)
Add
Compare
Today's Range
$8.90
Now: $9.05
$9.06
50-Day Range
$8.83
MA: $9.22
$9.54
52-Week Range
$8.05
Now: $9.05
$18.23
Volume1,025 shs
Average Volume41,212 shs
Market Capitalization$38.53 million
P/E Ratio5.26
Dividend YieldN/A
Beta0.76

Headlines

Opiant Pharmaceuticals (NASDAQ OPNT) News Headlines

Source:
DateHeadline
Zacks Investment Research Analysts Lift Earnings Estimates for Opiant Pharmaceuticals Inc (NASDAQ:OPNT)Zacks Investment Research Analysts Lift Earnings Estimates for Opiant Pharmaceuticals Inc (NASDAQ:OPNT)
americanbankingnews.com - August 12 at 9:08 AM
OPNT: Expecting $26 Million in NARCAN® Nasal Spray Royalties in 2020…OPNT: Expecting $26 Million in NARCAN® Nasal Spray Royalties in 2020…
finance.yahoo.com - August 10 at 3:43 PM
Opiant Pharmaceuticals (NASDAQ:OPNT) Releases Quarterly  Earnings Results, Beats Estimates By $0.26 EPSOpiant Pharmaceuticals (NASDAQ:OPNT) Releases Quarterly Earnings Results, Beats Estimates By $0.26 EPS
americanbankingnews.com - August 9 at 9:51 PM
Opiant Pharmaceuticals, Inc. (OPNT) CEO Roger Crystal on Q2 2020 Results - Earnings Call TranscriptOpiant Pharmaceuticals, Inc. (OPNT) CEO Roger Crystal on Q2 2020 Results - Earnings Call Transcript
seekingalpha.com - August 9 at 8:10 AM
$6.47 Million in Sales Expected for Opiant Pharmaceuticals Inc (NASDAQ:OPNT) This Quarter$6.47 Million in Sales Expected for Opiant Pharmaceuticals Inc (NASDAQ:OPNT) This Quarter
www.americanbankingnews.com - August 7 at 1:34 PM
Opiant Pharmaceuticals Inc (NASDAQ:OPNT) Short Interest UpdateOpiant Pharmaceuticals Inc (NASDAQ:OPNT) Short Interest Update
www.americanbankingnews.com - August 7 at 12:48 AM
Opiant Pharmaceuticals EPS beats by $0.19, beats on revenueOpiant Pharmaceuticals EPS beats by $0.19, beats on revenue
seekingalpha.com - August 6 at 9:08 PM
Opiant Pharmaceuticals Announces Second Quarter 2020 Financial Results and Corporate UpdateOpiant Pharmaceuticals Announces Second Quarter 2020 Financial Results and Corporate Update
finance.yahoo.com - August 6 at 9:08 PM
 Brokerages Expect Opiant Pharmaceuticals Inc (NASDAQ:OPNT) to Announce -$0.31 Earnings Per Share Brokerages Expect Opiant Pharmaceuticals Inc (NASDAQ:OPNT) to Announce -$0.31 Earnings Per Share
americanbankingnews.com - August 5 at 9:06 PM
Opiant Pharmaceuticals (OPNT) to Release Quarterly Earnings on ThursdayOpiant Pharmaceuticals (OPNT) to Release Quarterly Earnings on Thursday
www.americanbankingnews.com - July 30 at 5:21 AM
Opiant Pharmaceuticals to Report Second Quarter 2020 Financial Results and Host Conference Call and Webcast on August 6, 2020Opiant Pharmaceuticals to Report Second Quarter 2020 Financial Results and Host Conference Call and Webcast on August 6, 2020
finance.yahoo.com - July 23 at 5:37 PM
Stans Energy (OTCMKTS:HREEF) versus Opiant Pharmaceuticals (OTCMKTS:OPNT) Critical SurveyStans Energy (OTCMKTS:HREEF) versus Opiant Pharmaceuticals (OTCMKTS:OPNT) Critical Survey
www.americanbankingnews.com - July 23 at 4:20 PM
Edited Transcript of OPNT earnings conference call or presentation 12-May-20 8:30pm GMTEdited Transcript of OPNT earnings conference call or presentation 12-May-20 8:30pm GMT
finance.yahoo.com - June 21 at 6:41 PM
EBS, OPNT among premarket losersEBS, OPNT among premarket losers
seekingalpha.com - June 8 at 9:41 AM
Hedge Funds Getting Bullish On Opiant Pharmaceuticals, Inc. (OPNT)Hedge Funds Getting Bullish On Opiant Pharmaceuticals, Inc. (OPNT)
finance.yahoo.com - June 4 at 10:01 PM
Opiant Pharmaceuticals to Present at the 2020 Jefferies Virtual Healthcare ConferenceOpiant Pharmaceuticals to Present at the 2020 Jefferies Virtual Healthcare Conference
finance.yahoo.com - May 26 at 7:54 PM
Is Weakness In Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?Is Weakness In Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?
finance.yahoo.com - May 25 at 5:47 PM
Opiant Pharmaceuticals to Hold Virtual 2020 Annual Shareholder MeetingOpiant Pharmaceuticals to Hold Virtual 2020 Annual Shareholder Meeting
finance.yahoo.com - May 21 at 6:29 PM
OPNT: NDA Filing for OPNT003 in Early 2021…OPNT: NDA Filing for OPNT003 in Early 2021…
finance.yahoo.com - May 15 at 12:47 PM
Opiant Pharmaceuticals (OPNT) CEO Roger Crystal on Q1 2020 Results - Earnings Call TranscriptOpiant Pharmaceuticals' (OPNT) CEO Roger Crystal on Q1 2020 Results - Earnings Call Transcript
seekingalpha.com - May 12 at 10:47 PM
Opiant Pharmaceuticals EPS misses by $0.21, misses on revenueOpiant Pharmaceuticals EPS misses by $0.21, misses on revenue
seekingalpha.com - May 12 at 5:46 PM
Opiant Pharmaceuticals Announces First Quarter 2020 Financial Results and Corporate UpdateOpiant Pharmaceuticals Announces First Quarter 2020 Financial Results and Corporate Update
finance.yahoo.com - May 12 at 5:46 PM
Opiant Pharmaceuticals to Report First Quarter 2020 Financial Results and Host Conference Call and Webcast on Tuesday, May 12Opiant Pharmaceuticals to Report First Quarter 2020 Financial Results and Host Conference Call and Webcast on Tuesday, May 12
finance.yahoo.com - April 28 at 11:18 AM
If You Had Bought Opiant Pharmaceuticals (NASDAQ:OPNT) Stock Five Years Ago, You Could Pocket A 63% Gain TodayIf You Had Bought Opiant Pharmaceuticals (NASDAQ:OPNT) Stock Five Years Ago, You Could Pocket A 63% Gain Today
finance.yahoo.com - March 26 at 6:18 PM
Edited Transcript of OPNT earnings conference call or presentation 4-Mar-20 9:30pm GMTEdited Transcript of OPNT earnings conference call or presentation 4-Mar-20 9:30pm GMT
finance.yahoo.com - March 24 at 1:23 PM
OPNT: Pivotal PK Study for OPNT003 to Initiate in 2Q20…OPNT: Pivotal PK Study for OPNT003 to Initiate in 2Q20…
finance.yahoo.com - March 9 at 1:39 PM
Opiant Pharmaceuticals (OPNT) CEO Roger Crystal on Q4 2019 Results - Earnings Call TranscriptOpiant Pharmaceuticals' (OPNT) CEO Roger Crystal on Q4 2019 Results - Earnings Call Transcript
seekingalpha.com - March 5 at 9:20 AM
Opiant Pharmaceuticals EPS beats by $0.02, beats on revenueOpiant Pharmaceuticals EPS beats by $0.02, beats on revenue
seekingalpha.com - March 4 at 7:48 PM
Opiant Pharmaceuticals Reports Fourth Quarter and Full-Year 2019 Financial Results and Provides Corporate UpdateOpiant Pharmaceuticals Reports Fourth Quarter and Full-Year 2019 Financial Results and Provides Corporate Update
finance.yahoo.com - March 4 at 7:48 PM
Opiant Pharmaceuticals to Report Fourth Quarter 2019 Financial Results and Host Conference Call and Webcast on Wednesday, March 4Opiant Pharmaceuticals to Report Fourth Quarter 2019 Financial Results and Host Conference Call and Webcast on Wednesday, March 4
finance.yahoo.com - February 24 at 7:21 PM
Is Opiant Pharmaceuticals, Inc.'s (NASDAQ:OPNT) CEO Pay Justified?Is Opiant Pharmaceuticals, Inc.'s (NASDAQ:OPNT) CEO Pay Justified?
finance.yahoo.com - January 24 at 10:04 AM
Opiant inks collaboration deal to develop OPNT004 for acute cannabinoid overdoseOpiant inks collaboration deal to develop OPNT004 for acute cannabinoid overdose
seekingalpha.com - January 2 at 3:48 PM
Opiant Pharmaceuticals Announces Development Collaboration with National Center for Advancing Translational Sciences for the Development of OPNT004 for the Treatment of Acute Cannabinoid OverdoseOpiant Pharmaceuticals Announces Development Collaboration with National Center for Advancing Translational Sciences for the Development of OPNT004 for the Treatment of Acute Cannabinoid Overdose
finance.yahoo.com - January 2 at 3:48 PM
Opiant nabs second tranche of BARDA contract for nasal nalmefeneOpiant nabs second tranche of BARDA contract for nasal nalmefene
seekingalpha.com - December 12 at 7:04 PM
Opiant Pharmaceuticals Announces Contract Extension of Second Tranche of Approximately $2.4 Million from Biomedical Advanced Research and Development Authority for Development of OPNT003, Nasal Nalmefene, for the Treatment of Opioid OverdoseOpiant Pharmaceuticals Announces Contract Extension of Second Tranche of Approximately $2.4 Million from Biomedical Advanced Research and Development Authority for Development of OPNT003, Nasal Nalmefene, for the Treatment of Opioid Overdose
finance.yahoo.com - December 12 at 7:04 PM
A Closer Look At Opiant Pharmaceuticals, Inc.s (NASDAQ:OPNT) Uninspiring ROEA Closer Look At Opiant Pharmaceuticals, Inc.'s (NASDAQ:OPNT) Uninspiring ROE
finance.yahoo.com - December 10 at 10:35 PM
A Closer Look At Opiant Pharmaceuticals, Inc.'s (NASDAQ:OPNT) Uninspiring ROEA Closer Look At Opiant Pharmaceuticals, Inc.'s (NASDAQ:OPNT) Uninspiring ROE
finance.yahoo.com - December 10 at 12:34 PM
Opiant Pharmaceuticals, Inc. (OPNT): Hedge Funds Watching From AfarOpiant Pharmaceuticals, Inc. (OPNT): Hedge Funds Watching From Afar
finance.yahoo.com - November 24 at 4:40 PM
Opiant Pharmaceuticals, Inc. Common Stock (OPNT) Insider ActivityOpiant Pharmaceuticals, Inc. Common Stock (OPNT) Insider Activity
www.nasdaq.com - November 21 at 10:50 PM
Edited Transcript of OPNT earnings conference call or presentation 12-Nov-19 9:30pm GMTEdited Transcript of OPNT earnings conference call or presentation 12-Nov-19 9:30pm GMT
finance.yahoo.com - November 21 at 12:47 PM
OPNT: Research and Development Meeting Highlights Development Products…OPNT: Research and Development Meeting Highlights Development Products…
finance.yahoo.com - November 13 at 3:16 PM
The Daily Biotech Pulse: Merck Goes Shopping, Nuvectra Files For Bankruptcy Protection, Opiant Rips HigherThe Daily Biotech Pulse: Merck Goes Shopping, Nuvectra Files For Bankruptcy Protection, Opiant Rips Higher
www.msn.com - November 13 at 8:52 AM
Opiant Pharmaceuticals, Inc. (OPNT) CEO Roger Crystal on Q3 2019 Results - Earnings Call TranscriptOpiant Pharmaceuticals, Inc. (OPNT) CEO Roger Crystal on Q3 2019 Results - Earnings Call Transcript
seekingalpha.com - November 12 at 10:09 PM
Opiant Pharmaceuticals EPS beats by $2.10, beats on revenueOpiant Pharmaceuticals EPS beats by $2.10, beats on revenue
seekingalpha.com - November 12 at 5:08 PM
Opiant Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Corporate UpdateOpiant Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Corporate Update
finance.yahoo.com - November 12 at 5:08 PM
Opiant Pharmaceuticals to Report Third Quarter 2019 Financial Results and Host Conference Call and Webcast on Tuesday, November 12Opiant Pharmaceuticals to Report Third Quarter 2019 Financial Results and Host Conference Call and Webcast on Tuesday, November 12
finance.yahoo.com - November 5 at 8:43 AM
Can You Imagine How Chuffed Opiant Pharmaceuticalss (NASDAQ:OPNT) Shareholders Feel About Its 227% Share Price Gain?Can You Imagine How Chuffed Opiant Pharmaceuticals's (NASDAQ:OPNT) Shareholders Feel About Its 227% Share Price Gain?
finance.yahoo.com - October 14 at 6:12 PM
Can You Imagine How Chuffed Opiant Pharmaceuticals's (NASDAQ:OPNT) Shareholders Feel About Its 227% Share Price Gain?Can You Imagine How Chuffed Opiant Pharmaceuticals's (NASDAQ:OPNT) Shareholders Feel About Its 227% Share Price Gain?
finance.yahoo.com - October 14 at 6:12 PM
Opiant Pharmaceuticals to Host a Research & Development Meeting on Emerging Therapeutics for the Treatment of Addiction and Drug OverdoseOpiant Pharmaceuticals to Host a Research & Development Meeting on Emerging Therapeutics for the Treatment of Addiction and Drug Overdose
finance.yahoo.com - October 10 at 12:59 PM
Opiant Pharmaceuticals to Present at the 2019 Cantor Global Healthcare ConferenceOpiant Pharmaceuticals to Present at the 2019 Cantor Global Healthcare Conference
finance.yahoo.com - September 24 at 5:34 PM
This page was last updated on 8/14/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.